Center-Authored Papers

Filters: Author is Champlin, Richard E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
2009
Wang Y, Li D, Jones D, Bassett R, Sale GE, Khalili J, Komanduri KV, Couriel DR, Champlin RE, Molldrem JJ et al..  2009.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(12):1513-22. Abstract
2011
Samuelson S, Sandmaier BM, Heslop HE, Popat U, Carrum G, Champlin RE, Storb R, Prchal JT, Gooley TA, Deeg HJ.  2011.  Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.. British journal of haematology. 153(1):76-82. Abstract
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
2012
Ma Q, Li D, Nurieva R, Patenia R, Bassett R, Cao W, Alekseev AM, He H, Molldrem JJ, Kroll MH et al..  2012.  Reduced Graft-versus-Host Disease in C3-Deficient Mice Is Associated with Decreased Donor Th1/Th17 Differentiation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Brunstein CG, Eapen M, Woo Ahn K, Appelbaum FR, Ballen KK, Champlin RE, Cutler C, Kan F, Laughlin MJ, Soiffer RJ et al..  2012.  Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.. Blood. 119(23):5591-8. Abstract
2013
Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y, Crossland DL, Huls H, Littman N, Zhang Z et al..  2013.  Towards eliminating HLA class I expression to generate universal cells from allogeneic donors.. Blood. 122(8):1341-9. Abstract
2014
Eckrich MJ, Ahn K-W, Champlin RE, Coccia P, Godder K, Horan J, Margolis D, Deeg HJ, Eapen M.  2014.  Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.. American journal of hematology. 89(2):125-9. Abstract
Duong HK, Savani BN, Copelan E, Devine S, Costa LJ, Wingard JR, Shaughnessy P, Majhail N, Perales M-A, Cutler CS et al..  2014.  Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines of the American Society for Blood and Marrow Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
Kanakry CG, O'Donnell PV, Furlong T, de Lima MJ, Wei W, Medeot M, Mielcarek M, Champlin RE, Jones RJ, Thall PF et al..  2014.  Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(31):3497-505. Abstract
336
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
Adolescent
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
Adult
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract
Age Factors
Samuelson S, Sandmaier BM, Heslop HE, Popat U, Carrum G, Champlin RE, Storb R, Prchal JT, Gooley TA, Deeg HJ.  2011.  Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.. British journal of haematology. 153(1):76-82. Abstract
Aged
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP et al..  2008.  Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.. Blood. 112(8):3500-7. Abstract
Samuelson S, Sandmaier BM, Heslop HE, Popat U, Carrum G, Champlin RE, Storb R, Prchal JT, Gooley TA, Deeg HJ.  2011.  Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age.. British journal of haematology. 153(1):76-82. Abstract
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
Anemia, Aplastic
Lee SJ, Joffe S, Artz AS, Champlin RE, Davies SM, Jagasia M, Kernan NA, Loberiza FR, Soiffer RJ, Eapen M.  2008.  Individual physician practice variation in hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(13):2162-70. Abstract
Animals
Wang Y, Li D, Jones D, Bassett R, Sale GE, Khalili J, Komanduri KV, Couriel DR, Champlin RE, Molldrem JJ et al..  2009.  Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(12):1513-22. Abstract
Antineoplastic Agents
Eapen M, Logan BR, Horowitz MM, Zhong X, Perales M-A, Lee SJ, Rocha V, Soiffer RJ, Champlin RE.  2015.  Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(4):364-9. Abstract